Editorial: Association of diabetes mellitus with cognitive impairment and neurological disorders, volume II
-
By
-
Kexin Zhang
-
Lei Sha
-
Xiaodong Sun
-
June 18, 2026
-
Clinical Scorecard: Link Between Diabetes Mellitus and Cognitive Decline Alongside Neurological Disorders
At a Glance
| Category | Detail |
|---|
| Condition | Diabetes Mellitus and Cognitive Decline |
| Key Mechanisms | Hyperglycemia, insulin resistance, vascular and inflammatory dysfunction |
| Target Population | Individuals with Type 2 Diabetes Mellitus (T2DM) |
| Care Setting | Clinical and population-based studies |
Key Highlights
- Cognitive deficits in diabetes affect memory, executive functions, and attention.
- Insulin resistance and chronic hyperglycemia are key determinants of cognitive decline.
- Pharmacological strategies may mitigate cognitive decline beyond glycemic control.
- Metabolic dysfunction predisposes individuals to cognitive deficits.
- Age and metabolic control influence susceptibility and reversibility of cognitive deficits.
Guideline-Based Recommendations
Diagnosis
- Identify cognitive impairment through comprehensive assessments in T2DM patients.
Management
- Implement targeted interventions addressing metabolic, vascular, and inflammatory factors.
Monitoring & Follow-up
- Regularly assess cognitive function and metabolic parameters in T2DM patients.
Risks
- Monitor for increased risk of cognitive decline associated with insulin resistance and hyperglycemia.
Patient & Prescribing Data
Elderly and middle-aged individuals with Type 2 Diabetes Mellitus
SGLT2 inhibitors and GLP-1 receptor agonists may provide neuroprotective benefits.
Clinical Best Practices
- Adopt rigorous methodological practices in research on T2DM and cognitive impairment.
- Encourage early glycemic control to mitigate cognitive deficits in children and adolescents with T1D.
- Utilize a multidisciplinary approach to address the multifactorial nature of cognitive impairment.
Related Resources & Content
